Pharming says FDA accepts Joenja pediatric sNDA, sets Jan. 30, 2027 PDUFA date

By Public Technologies
  • Pharming won FDA Priority Review for a Joenja label expansion in APDS to cover children aged 4+ weighing 13 kg to 27 kg.
  • PDUFA action date set for Jan. 30, 2027.
  • Approval would extend access beyond the current U.S. indication for ages 4-11 weighing at least 27 kg.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharming Group NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609251030PRIMZONEFULLFEED1001274630) on September 25, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk